Generic Name
Tc-99M Exametazime
Brand Names
Ceretec, Drax Exametazime
FDA approval date: December 30, 1988
Classification: Radioactive Diagnostic Agent
Form: Injection, Kit
What is Ceretec (Tc-99M Exametazime)?
Ceretec is a radioactive diagnostic agent, indicated in adults and pediatric patients age 2 to 17 for: Leukocyte Labeled Scintigraphy – As an adjunct in the localization of intraabdominal infection and inflammatory bowel disease.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment